Livanova PLC Form 4 insider transactions

Director William A. Kozy acquired 4,840 Restricted Stock Units (RSUs) of LivaNova PLC on June 15, 2024, which will vest on June 15, 2025.

Director Sharon O'Kane reports acquisition and disposal of LivaNova PLC ordinary shares related to restricted stock units.

Director Brooke Story reports acquisition and disposal of LivaNova PLC ordinary shares related to restricted stock units.

Director Daniel Jeffrey Moore exercised options and sold LivaNova PLC shares under a pre-arranged 10b5-1 trading plan.

Stephanie Bolton, President of Global Epilepsy at LivaNova PLC, reports the vesting and acquisition of restricted stock units (RSUs), performance stock units (PSUs), and stock appreciation rights (SARs) on March 30, 2024.

Director William Kozy reports the acquisition of 1,034 Restricted Stock Units (RSUs) in LivaNova PLC on March 30, 2024, vesting on March 30, 2025.

Chief Human Resources Officer of LivaNova PLC, Trui Hebbelinck, reports acquisition and disposal of ordinary shares and derivative securities, including restricted stock units and performance stock units, on March 30, 2024.

LivaNova PLC's CEO, Vladimir Makatsaria, was granted restricted stock units, performance stock units, and stock appreciation rights on March 30, 2024, under the company's 2022 Incentive Award Plan.

CFO of LivaNova PLC, Alex Shvartsburg, reports acquisition and disposal of ordinary shares, restricted stock units (RSUs), performance stock units (PSUs), and stock appreciation rights (SARs) on March 30, 2024.

Michael Damon Hutchinson, Chief Legal Officer of LivaNova PLC, reports acquisition and disposal of ordinary shares and grants of restricted stock units, performance stock units, and stock appreciation rights.

William Kozy, Chairman and CEO of LivaNova PLC, reports the acquisition and disposal of ordinary shares related to vested restricted stock units (RSUs) to satisfy tax obligations.